Profile picture

Doctor Afshin Farzaneh-Far

Solid Biosciences, Boston (United States of America)
Membership: ESC Professional Member EHRA Member
Follow
Logo ESC

Contributor content

Gene therapy for catecholaminergic polymorphic ventricular tachycardia (CPVT): IND-enabling data and design of the ARTEMIS Phase 1b clinical trial
Presentation
Gene therapy for catecholaminergic polymorphic ventricular tachycardia (CPVT): IND-enabling data and design of the ARTEMIS Phase 1b clinical trial

ESC 365 is supported by